Medical News |
- Continuity of care protects mental health patients
- Everolimus fails to boost advanced NSCLC response
- Everolimus fails to boost advanced NSCLC response
- Continuity of care protects mental health patients
- Hippocampal activity may reflect ‘core’ schizophrenia traits
- Continuity of care protects mental health patients
- Hippocampal activity may reflect ‘core’ schizophrenia traits
| Continuity of care protects mental health patients Posted: 27 Jan 2014 04:00 PM PST Research shows that seeing the same psychiatrist over time is associated with reduced mortality in patients using mental health services, particularly those with bipolar disorder, major depressive disorder, or schizophrenia. |
| Everolimus fails to boost advanced NSCLC response Posted: 27 Jan 2014 04:00 PM PST Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy. |
| Everolimus fails to boost advanced NSCLC response Posted: 27 Jan 2014 04:00 PM PST Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy. |
| Continuity of care protects mental health patients Posted: 27 Jan 2014 04:00 PM PST Research shows that seeing the same psychiatrist over time is associated with reduced mortality in patients using mental health services, particularly those with bipolar disorder, major depressive disorder, or schizophrenia. |
| Hippocampal activity may reflect ‘core’ schizophrenia traits Posted: 27 Jan 2014 04:00 PM PST Hippocampal function may be a useful biomarker for the response of patients with schizophrenia to medication, research suggests. |
| Continuity of care protects mental health patients Posted: 27 Jan 2014 04:00 PM PST Research shows that seeing the same psychiatrist over time is associated with reduced mortality in patients using mental health services, particularly those with bipolar disorder, major depressive disorder, or schizophrenia. |
| Hippocampal activity may reflect ‘core’ schizophrenia traits Posted: 27 Jan 2014 04:00 PM PST Hippocampal function may be a useful biomarker for the response of patients with schizophrenia to medication, research suggests. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment